EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
84 hedge funds and large institutions have $191M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+6
Holders Change %
+7.69%
% of All Funds
1.84%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
15
Increased
30
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$3.15M |
2 |
2
Northern Trust
Chicago,
Illinois
|
$3.06M |
3 |
CS
3
Credit Suisse
Zurich,
Switzerland
|
$1.39M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$4.41M |
5 |
FCM
5
Farallon Capital Management
San Francisco,
California
|
$11.5M |